Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail)

v3.23.2
NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Common stock issued under the backstop agreement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 9,600,031 9,600,031 9,600,031 9,600,031
Grants of restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 6,049,919 3,441,651 5,332,210 3,275,885
Private placement warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 272,779 272,779 272,779 272,779